-

Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4

Live Webcast at 3:30 p.m. CT (4:30 p.m. ET)

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 first-quarter conference call on Wednesday, November 4, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2020, and its financial outlook. CSI will issue a post-market earnings release prior to the call on November 4, 2020.

To access the live webcast, go to the events section of CSI’s investor relations website, https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx, on the day of the conference, and click on the webcast link. A webcast replay will be available beginning at 6:30 p.m. CT the same day.

To participate in the conference call, please register online prior to the event: http://www.directeventreg.com/registration/event/6292177.

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com

Cardiovascular Systems, Inc.

NASDAQ:CSII

Release Versions

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com

More News From Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. COMPLETES ENROLLMENT OF ECLIPSE CLINICAL TRIAL...

Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS...

Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. TO HOST EARNINGS CONFERENCE CALL ON FEBRUARY 9, 2023...
Back to Newsroom